Literature DB >> 17603056

Comparison of serum and plasma measurements of Müllerian inhibiting substance.

Zaher O Merhi1, Geralyn M Messerlian, Howard Minkoff, Elizabeth E Eklund, Jerzy Macura, Joseph Feldman, Carlos Rodriguez, David B Seifer.   

Abstract

The authors sought to determine whether measurement of plasma Müllerian inhibiting substance (MIS) is a suitable substitute for measurement of serum MIS. Eighteen samples of serum and plasma were examined that were drawn simultaneously. Levels of MIS were measured with an ELISA kit, and plasma levels were studied in parallel to serum samples. A 98.5% correlation was found between serum and plasma MIS values.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17603056     DOI: 10.1016/j.fertnstert.2007.05.041

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

1.  Anti-Müllerian hormone and lifestyle, reproductive, and environmental factors among women in rural South Africa.

Authors:  Kristina W Whitworth; Donna D Baird; Anne Z Steiner; Riana M S Bornman; Gregory S Travlos; Ralph E Wilson; Matthew P Longnecker
Journal:  Epidemiology       Date:  2015-05       Impact factor: 4.822

2.  Vitamin D alters genes involved in follicular development and steroidogenesis in human cumulus granulosa cells.

Authors:  Zaher Merhi; Angela Doswell; Kendall Krebs; Marilyn Cipolla
Journal:  J Clin Endocrinol Metab       Date:  2014-03-14       Impact factor: 5.958

3.  Anti-Mullerian hormone and endometrial cancer: a multi-cohort study.

Authors:  Renée T Fortner; Helena Schock; Seungyoun Jung; Naomi E Allen; Alan A Arslan; Louise A Brinton; Brian L Egleston; Roni T Falk; Marc J Gunter; Kathy J Helzlsouer; Annika Idahl; Theron S Johnson; Rudolf Kaaks; Vittorio Krogh; Eva Lundin; Melissa A Merritt; Carmen Navarro; N Charlotte Onland-Moret; Domenico Palli; Xiao-Ou Shu; Patrick M Sluss; Paul N Staats; Antonia Trichopoulou; Elisabete Weiderpass; Anne Zeleniuch-Jacquotte; Wei Zheng; Joanne F Dorgan
Journal:  Br J Cancer       Date:  2017-09-05       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.